MDR1-mediated drug resistance in Candida dubliniensis

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 12, 2001, Pages 3416-3421

  Wirsching, S ^a   Moran, G P ^a   Sullivan, D J ^a   Coleman, D C ^a   Morschhauser J ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; AMOROLFINE; ANTIFUNGAL AGENT; BENOMYL; BREFELDIN A; CERULENIN; CRYSTAL VIOLET; DIMETHYL SULFOXIDE; FLUCONAZOLE; FLUPHENAZINE; FUNGAL DNA; KETOCONAZOLE; TERBINAFINE;

AMINO ACID SEQUENCE; ARTICLE; CANDIDA; CANDIDA DUBLINIENSIS; CANDIDIASIS; DELETION MUTANT; DNA FINGERPRINTING; GENE OVEREXPRESSION; MULTIDRUG RESISTANCE; MYCOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; STRAIN DIFFERENCE;

ANTIFUNGAL AGENTS; BLOTTING, SOUTHERN; CANDIDA; CANDIDA ALBICANS; CHROMOSOMES, FUNGAL; CULTURE MEDIA; DNA FINGERPRINTING; DNA, FUNGAL; DRUG RESISTANCE, MICROBIAL; FLUCONAZOLE; GENE DELETION; GENES, FUNGAL; GENES, MDR; MUTATION;

EID: 0035191374     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.12.3416-3421.2001     Document Type: Article

References (21)

1. Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene
2. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate
3. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains
4. gene
5. Identification of polymorphic mutant alleles of CaMDR1, a major facilitator of Candida albicans which confers multidrug resistance, and its in vitro transcriptional activation
6. Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis
7. Overexpression of a cloned IMP dehydrogenase gene of Candida albicans confers resistance to the specific inhibitor mycophenolic acid
8. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: Persistence of Candida albicans strains with the same genotype
9. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis
10. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro
11. Sequential gene disruption in Candida albicans by FLP-mediated site-specific recombination
12. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection
13. Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS
14. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterization of CDR2, a new multidrug ABC transporter gene
15. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors
16. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
17. Isogenic strain construction and gene targeting in Candida dubliniensis
18. Candida dubliniensis: Characteristics and identification
19. Candida dubliniensis sp. nov.: Phenotypic and molecular characterization of a novel species associated with oral candidosis in HIVinfected individuats
20. Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor
21. Targeted gene disruption in Candida albicans witd-type strains: The rote of the MDR1 gene in fluconazole resistance of ctinical Candida albicans isotates